We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Bioengineers Present Glucose Monitor Tattoo Prototype

By LabMedica International staff writers
Posted on 25 Jan 2015
Print article
Image: Bioengineers have tested a flexible and easy to wear temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells (Photo courtesy of the University of California, San Diego).
Image: Bioengineers have tested a flexible and easy to wear temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells (Photo courtesy of the University of California, San Diego).
A team of bioengineers has presented a prototype "proof-of-concept" version of a temporary tattoo that is able to extract and measure the level of glucose in the fluid between human skin cells.

The flexible, easy to wear device consists of a pattern of electrodes printed on temporary tattoo paper that is attached to the skin. When a mild electrical current is applied to the skin for about 10 minutes, sodium ions and glucose molecules in the interstitial fluid migrate toward the tattoo's electrodes. A sensor built into the tattoo measures the strength of the electrical charge produced by the glucose to determine the patient's overall glucose level.

In a preliminary study, tattoos were applied to seven men and women between the ages of 20 and 40 with no history of diabetes. The volunteers were fed a carbohydrate-rich meal, and glucose levels were monitored by the tattoo and compared to those obtained by the traditional finger-stick method. Results showed that the tattoos detected the glucose spike following the meal with the same level of accuracy as the finger-stick.

"The concentration of glucose extracted by the noninvasive tattoo device is almost hundred times lower than the corresponding level in the human blood," said first author Amay Bandodkar, a graduate researcher at the University of California, San Diego (USA). "Thus we had to develop a highly sensitive glucose sensor that could detect such low levels of glucose with high selectivity. Eventually the instrument will also have Bluetooth readout capabilities to send this information directly to the patient's doctor in real-time or store data in the cloud. Presently the tattoo sensor can easily survive for a day. These are extremely inexpensive—a few cents—and hence can be replaced without much financial burden on the patient."

The paper describing the potential for glucose monitoring with a noninvasive flexible tattoo was published in the December 12, 2014, online edition of the journal Analytical Chemistry.

Related Links:

University of California, San Diego


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.